Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy

Keyphrases

• In-stent Restenosis 100%
• Sirolimus-eluting Stent 100%
• Angiographic Outcome 100%
• Clinical Outcomes 100%
• Endovascular Brachytherapy 100%
• Brachytherapy 23%
• Low Incidence 15%
• Intracoronary Brachytherapy 15%
• Stent 7%
• Coronary Artery Disease 7%
• Myocardial Infarction 7%
• Group 14 7%
• Clinical Efficacy 7%
• Target Lesion 7%
• Statistical Significance 7%
• Stent Implantation 7%
• Clinical Problems 7%
• Rapamycin 7%
• Restenosis 7%
• Nonrandomized Studies 7%
• Coronary Stent 7%
• Surgical Revascularization 7%
• Sirolimus 7%
• Revascularization Rate 7%
• Late Luminal Loss 7%
• Target Vessel Revascularization 7%

Medicine and Dentistry

• Brachytherapy 100%
• In-Stent Restenosis 100%
• Rapamycin 100%
• Restenosis 16%
• Coronary Artery Disease 8%
• Myocardial Infarction 8%
• Stenting 8%
• Revascularization 8%
• Target Vessel Revascularization 8%
• Target Lesion 8%

Pharmacology, Toxicology and Pharmaceutical Science

• In-Stent Restenosis 100%
• Rapamycin 100%
• Restenosis 16%
• Heart Infarction 8%
• Coronary Artery Disease 8%